Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 31, 2026 4 hours, 6 minutes ago
Medical News: A team of scientists from the Herbert Wertheim College of Medicine at Florida International University in the United States, together with collaborators from the University of South Alabama, has uncovered a previously unknown molecular player that may help explain why brain inflammation becomes so severe in Alzheimer’s disease. Their work focuses on a newly identified long noncoding RNA, or lncRNA, called LIMASI, which appears to intensify harmful inflammatory activity in the Alzheimer’s brain.
A newly discovered RNA molecule may help explain why inflammation accelerates brain damage in
Alzheimer’s disease
Understanding Alzheimer’s and Brain Inflammation
Alzheimer’s disease is best known for memory loss and cognitive decline, but deep inside the brain, chronic inflammation is now recognized as a major driver of damage. Inflammation is normally part of the body’s defense system, yet when it remains switched on for too long in the brain, it can accelerate nerve cell injury, worsen amyloid plaque buildup, and promote abnormal tau protein changes. Scientists have been searching for the molecular switches that keep this inflammatory process running.
Discovery of a New RNA Player
The researchers identified LIMASI, a long noncoding RNA that does not make proteins but instead influences how other genes behave. By examining postmortem brain tissues from Alzheimer’s patients and comparing them with healthy controls, the team found that LIMASI levels were more than five times higher in Alzheimer’s brains. Importantly, this increase was closely linked with heavier amyloid plaque deposits, higher levels of abnormal tau proteins, and strong activation of inflammatory signals.
Evidence from Human Brains and Animal Models
To strengthen their findings, the scientists studied a well-established Alzheimer’s mouse model known as 3xTg AD mice. These animals develop memory related brain changes similar to those seen in humans. The mice also showed significantly elevated LIMASI levels alongside sharp rises in inflammatory molecules such as interleukin 6 and ICAM 1. This suggested that LIMASI is not merely a bystander but may actively contribute to inflammation across species.
How LIMASI May Worsen Inflammation
Further experiments revealed how LIMASI might work. The researchers discovered that LIMASI can act as a competing endogenous RNA, meaning it binds to and traps small regulatory molecules called microRNAs. These microRNAs normally help keep inflammation under control. When LIMASI soaks them up, inflammatory genes are left unchecked and become overactive. In simple terms, LIMASI appears to remove the brakes from the brain’s immune response.
Links to Infection Like Triggers
In laboratory cell studies, the team mimicked viral like immune stress and observed a rapid surge in LIMASI alongside inflammatory chemicals such as tumor necrosis factor and interleukin 1 beta. This suggests that infections or immune challenges might further amplify LIMASI driven inflammation in people already vulnerable
to Alzheimer’s disease. This
Medical News report highlights how immune triggers and genetic regulators may intersect in brain degeneration.
Why This Discovery Matters
Understanding LIMASI opens a new window into Alzheimer’s biology. Because LIMASI is strongly linked to inflammation, it could become a useful biomarker for tracking disease activity. More importantly, targeting LIMASI or its interactions with microRNAs might one day offer a way to calm harmful brain inflammation and slow disease progression.
Conclusion
Overall, this study provides compelling early evidence that LIMASI plays a central role in fueling Alzheimer’s related brain inflammation. By connecting genetic regulation, immune imbalance, and classic Alzheimer’s pathology, the findings offer a clearer picture of how inflammation spirals out of control. While more research is needed, especially in early-stage patients, LIMASI now stands out as a promising new target in the ongoing fight against Alzheimer’s disease.
The study findings were published on a preprint server and are currently being peer-reviewed.
https://www.preprints.org/manuscript/202601.1793
For the latest on Alzheimer research, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/alzheimer,-dementia-
Share
Tweet
Share
